Apyx Medical Statistics
Total Valuation
Apyx Medical has a market cap or net worth of $153.93 million. The enterprise value is $161.53 million.
Important Dates
The next estimated earnings date is Thursday, May 7, 2026, before market open.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Apyx Medical has 41.83 million shares outstanding. The number of shares has increased by 15.62% in one year.
| Current Share Class | 41.83M |
| Shares Outstanding | 41.83M |
| Shares Change (YoY) | +15.62% |
| Shares Change (QoQ) | +3.47% |
| Owned by Insiders (%) | 13.27% |
| Owned by Institutions (%) | 28.45% |
| Float | 29.09M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.91 |
| Forward PS | 2.61 |
| PB Ratio | 10.58 |
| P/TBV Ratio | 10.59 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.06 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.00, with a Debt / Equity ratio of 2.65.
| Current Ratio | 5.00 |
| Quick Ratio | 4.16 |
| Debt / Equity | 2.65 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.15 |
Financial Efficiency
Return on equity (ROE) is -76.15% and return on invested capital (ROIC) is -7.51%.
| Return on Equity (ROE) | -76.15% |
| Return on Assets (ROA) | -6.12% |
| Return on Invested Capital (ROIC) | -7.51% |
| Return on Capital Employed (ROCE) | -11.69% |
| Weighted Average Cost of Capital (WACC) | 12.43% |
| Revenue Per Employee | $257,776 |
| Profits Per Employee | -$54,688 |
| Employee Count | 205 |
| Asset Turnover | 0.80 |
| Inventory Turnover | 2.45 |
Taxes
In the past 12 months, Apyx Medical has paid $270,000 in taxes.
| Income Tax | 270,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +194.40% in the last 52 weeks. The beta is 1.54, so Apyx Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.54 |
| 52-Week Price Change | +194.40% |
| 50-Day Moving Average | 3.74 |
| 200-Day Moving Average | 3.06 |
| Relative Strength Index (RSI) | 50.34 |
| Average Volume (20 Days) | 160,240 |
Short Selling Information
The latest short interest is 164,872, so 0.39% of the outstanding shares have been sold short.
| Short Interest | 164,872 |
| Short Previous Month | 173,573 |
| Short % of Shares Out | 0.39% |
| Short % of Float | 0.57% |
| Short Ratio (days to cover) | 1.49 |
Income Statement
In the last 12 months, Apyx Medical had revenue of $52.84 million and -$11.21 million in losses. Loss per share was -$0.27.
| Revenue | 52.84M |
| Gross Profit | 33.04M |
| Operating Income | -6.45M |
| Pretax Income | -10.84M |
| Net Income | -11.21M |
| EBITDA | -5.79M |
| EBIT | -6.45M |
| Loss Per Share | -$0.27 |
Full Income StatementBalance Sheet
The company has $31.74 million in cash and $39.34 million in debt, with a net cash position of -$7.60 million or -$0.18 per share.
| Cash & Cash Equivalents | 31.74M |
| Total Debt | 39.34M |
| Net Cash | -7.60M |
| Net Cash Per Share | -$0.18 |
| Equity (Book Value) | 14.83M |
| Book Value Per Share | 0.35 |
| Working Capital | 46.77M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$8.00 million and capital expenditures -$1.11 million, giving a free cash flow of -$9.12 million.
| Operating Cash Flow | -8.00M |
| Capital Expenditures | -1.11M |
| Depreciation & Amortization | 655,000 |
| Net Borrowing | -20,000 |
| Free Cash Flow | -9.12M |
| FCF Per Share | -$0.22 |
Full Cash Flow StatementMargins
Gross margin is 62.53%, with operating and profit margins of -12.20% and -21.22%.
| Gross Margin | 62.53% |
| Operating Margin | -12.20% |
| Pretax Margin | -20.50% |
| Profit Margin | -21.22% |
| EBITDA Margin | -10.96% |
| EBIT Margin | -12.20% |
| FCF Margin | n/a |
Dividends & Yields
Apyx Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.62% |
| Shareholder Yield | n/a |
| Earnings Yield | -7.28% |
| FCF Yield | -5.92% |
Analyst Forecast
The average price target for Apyx Medical is $6.50, which is 76.63% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.50 |
| Price Target Difference | 76.63% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 46.88% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 6, 1994. It was a reverse split with a ratio of 1:15.
| Last Split Date | Jan 6, 1994 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
Apyx Medical has an Altman Z-Score of 0.38 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.38 |
| Piotroski F-Score | 3 |
